These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of mitral regurgitation in dogs: comparison of results of echocardiography with magnetic resonance imaging. Sargent J, Connolly DJ, Watts V, Mõtsküla P, Volk HA, Lamb CR, Fuentes VL. J Small Anim Pract; 2015 Nov; 56(11):641-50. PubMed ID: 26473746 [Abstract] [Full Text] [Related]
3. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease. Baron Toaldo M, Romito G, Guglielmini C, Diana A, Pelle NG, Contiero B, Cipone M. J Vet Intern Med; 2018 May; 32(3):914-921. PubMed ID: 29572938 [Abstract] [Full Text] [Related]
4. Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease. Tidholm A, Höglund K, Häggström J, Bodegård-Westling A, Ljungvall I. J Vet Intern Med; 2013 May; 27(4):884-9. PubMed ID: 23731204 [Abstract] [Full Text] [Related]
5. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease. Hezzell MJ, Boswood A, Moonarmart W, Elliott J. J Vet Cardiol; 2012 Mar; 14(1):269-79. PubMed ID: 22366569 [Abstract] [Full Text] [Related]
6. Comparisons of 2- and 3-dimensional echocardiographic methods for estimation of left atrial size in dogs with and without myxomatous mitral valve disease. Tidholm A, Bodegård-Westling A, Höglund K, Ljungvall I, Häggström J. J Vet Intern Med; 2011 Mar; 25(6):1320-7. PubMed ID: 22092623 [Abstract] [Full Text] [Related]
7. Two-dimensional, long-axis echocardiographic ratios for assessment of left atrial and ventricular size in dogs. Strohm LE, Visser LC, Chapel EH, Drost WT, Bonagura JD. J Vet Cardiol; 2018 Oct; 20(5):330-342. PubMed ID: 30143416 [Abstract] [Full Text] [Related]
8. Prognostic value of selected one-, two- and three-dimensional and Doppler echocardiographic methods to assess severity in dogs with myxomatous mitral valve disease. Tidholm A, Häggström J. J Vet Cardiol; 2022 Feb; 39():89-101. PubMed ID: 35008002 [Abstract] [Full Text] [Related]
10. Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs. Huh T, Achilles EJ, Massey LK, Loughran KA, Larouche-Lebel É, Convey V, McKaba VF, Crooks A, Kraus MS, Gelzer AR, Oyama MA. J Vet Intern Med; 2024 Feb; 38(3):1325-1333. PubMed ID: 38532734 [Abstract] [Full Text] [Related]
11. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease. Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME, Porciello F. J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124 [Abstract] [Full Text] [Related]
12. Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease. Müller S, Menciotti G, Borgarelli M. J Vet Cardiol; 2017 Oct; 19(5):433-440. PubMed ID: 28964709 [Abstract] [Full Text] [Related]
13. Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease. Larouche-Lebel É, Loughran KA, Oyama MA. J Vet Intern Med; 2019 Mar; 33(2):489-498. PubMed ID: 30793808 [Abstract] [Full Text] [Related]
14. The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs. Vezzosi T, Grosso G, Tognetti R, Meucci V, Patata V, Marchesotti F, Domenech O. J Vet Intern Med; 2021 May; 35(3):1238-1244. PubMed ID: 33951235 [Abstract] [Full Text] [Related]
15. Prognostic value of left atrial stiffness estimated using echocardiography in dogs with myxomatous mitral valve disease. Osuga T, Kuroda K, Morita T, Sasaki N, Nakamura K, Takiguchi M. J Vet Cardiol; 2023 Feb; 45():15-26. PubMed ID: 36608614 [Abstract] [Full Text] [Related]
16. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease. Borgarelli M, Abbott J, Braz-Ruivo L, Chiavegato D, Crosara S, Lamb K, Ljungvall I, Poggi M, Santilli RA, Haggstrom J. J Vet Intern Med; 2015 Feb; 29(2):569-74. PubMed ID: 25818210 [Abstract] [Full Text] [Related]
17. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A. J Vet Intern Med; 2008 Feb; 22(1):120-8. PubMed ID: 18289298 [Abstract] [Full Text] [Related]
18. Discrepancies in identification of left atrial enlargement using left atrial volume versus left atrial-to-aortic root ratio in dogs. Wesselowski S, Borgarelli M, Bello NM, Abbott J. J Vet Intern Med; 2014 Feb; 28(5):1527-33. PubMed ID: 25056960 [Abstract] [Full Text] [Related]
19. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease. Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL. J Vet Intern Med; 2024 Feb; 38(1):51-60. PubMed ID: 37909399 [Abstract] [Full Text] [Related]
20. The leaflet-annulus index in canine myxomatous mitral valve disease. Isaka M, Hisada S, Araki R, Ueno H. Res Vet Sci; 2022 Dec 20; 152():245-247. PubMed ID: 36029573 [Abstract] [Full Text] [Related] Page: [Next] [New Search]